Yi-Xiong Cao

MicroRNA let-7f is down-regulated in patients with refractory acute myeloid leukemia and is involved in chemotherapy resistance of adriamycin-resistant leukemic cells

C. Dai, Qing-Wei Bai, Guang-sen Zhang, 2014, Leukemia & lymphoma.

Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis

Guangxing Zhang, Xiaomin Liu, Yi-Xiong Cao, 2020, Cancer Gene Therapy.

LncRNA MALAT1 promotes cell proliferation and imatinib resistance by sponging miR-328 in chronic myelogenous leukemia.

Zeyu Luo, F. Wen, Yi-Xiong Cao, 2018, Biochemical and biophysical research communications.

Use of All-trans Retinoic Acid in Combination with Arsenic Trioxide for Remission Induction in Patients with Newly Diagnosed Acute Promyelocytic Leukemia and for Consolidation/Maintenance in CR Patients

Yun-xiao Xu, Hongling Peng, C. Dai, 2009, Acta Haematologica.

Downregulation of microRNA let‐7f mediated the Adriamycin resistance in leukemia cell line

Zeyu Luo, F. Wen, Jun-Jun Li, 2019, Journal of cellular biochemistry.

P53 suppresses the progression of hepatocellular carcinoma via miR‐15a by decreasing OGT expression and EZH2 stabilization

Guangxing Zhang, Xiaodong Peng, Yi-Xiong Cao, 2021, Journal of cellular and molecular medicine.

CircFBXW7 inhibits the tumorigenesis of T-cell acute lymphoblastic leukemia through modulating miR-494-3p/SOX1 axis

Zeyu Luo, Jun-Jun Li, Yi-Xiong Cao, 2022, Cell death discovery.